(Q55471194)

12 July 2018

title

Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. (English)

1 reference

12 July 2018

0 references

1 reference

Marie-Cécile Le Deley

15

object named as

Marie-Cécile Le Deley

0 references

François Doz

object named as

François Doz

7

0 references

Jacques Grill

1

object named as

Jacques Grill

1 reference

12 July 2018

6

Didier Frappaz

1 reference

12 July 2018

author name string

Christian Sainte-Rose

2

1 reference

12 July 2018

Anne Jouvet

3

1 reference

12 July 2018

Jean-Claude Gentet

4

1 reference

12 July 2018

Odile Lejars

5

1 reference

12 July 2018

Xavier Rialland

8

1 reference

12 July 2018

Fabienne Pichon

9

1 reference

12 July 2018

Anne-Isabelle Bertozzi

10

1 reference

12 July 2018

Pascal Chastagner

11

1 reference

12 July 2018

Dominique Couanet

12

1 reference

12 July 2018

Jean-Louis Habrand

13

1 reference

12 July 2018

Marie-Anne Raquin

14

1 reference

12 July 2018

Chantal Kalifa

16

1 reference

12 July 2018

French Society of Paediatric Oncology

17

1 reference

12 July 2018

publication date

1 August 2005

1 reference

12 July 2018

Lancet Oncology Commission

published in

1 reference

12 July 2018

volume

6

1 reference

12 July 2018

issue

8

1 reference

12 July 2018

page(s)

573-580

1 reference

12 July 2018

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Brain tumours under the age of three. The price of survival. A retrospective study of 20 long-term survivors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Recommendations of the Brain Tumor Subcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee. International Society of Pediatric Oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

One-sample multiple testing procedure for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Subsequent quality of life for children irradiated for a brain tumor before age four years.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

Visual agnosia after treatment of a posterior fossa ependymoma in a 16-month-old girl

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970252-7

7 January 2021

10.1016/S1470-2045(05)70252-7

Identifiers

DOI

1 reference

12 July 2018

PubMed ID

16054568

1 reference

12 July 2018